Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes-Reference-Cited by-同舟云学术

Pharmacotherapeutic management of comorbid polycystic ovary syndrome and diabetes

Published:2018-10-05 Issue:17 Volume:19 Page:1915-1926
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Ortiz-Flores Andrés E.¹^ORCID,Luque-Ramírez Manuel¹^ORCID,Escobar-Morreale Héctor F.¹^ORCID

Affiliation:

1. Diabetes, Obesity and Human Reproduction Research Group, Hospital Universitario Ramón y Cajal & Universidad de Alcalá & Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS) & Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain

Funder

Instituto de Salud Carlos III

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2018.1528231

Reference112 articles.

1. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

2. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment

3. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria

4. Prevalence and Characteristics of the Polycystic Ovary Syndrome in Overweight and Obese Women

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Could polyphenols be an effective treatment in the management of polycystic ovary syndrome?;International Journal for Vitamin and Nutrition Research;2024-06

2. Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs;Frontiers in Endocrinology;2024-01-11

3. Box Behnken optimization of cubosomes for enhancing the anticancer activity of metformin: Design, characterization, and in-vitro cell proliferation assay on MDA-MB-231 breast and LOVO colon cancer cell lines;International Journal of Pharmaceutics: X;2023-12

4. Circular RNA as a Novel Regulator and Promising Biomarker in Polycystic Ovary Syndrome;Biomolecules;2023-07-11

5. Therapeutic Efficacy of Extract From Polygonatum odoratum Druce on Polycystic Ovary Syndrome in Rats;PROG BIOCHEM BIOPHYS;2023